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she anterior mediastinum represents the second most
common site of germ cell tumor origin. Nonseminoma-
ous germ cell cancers not only comprise the main category of
he malignant germ cell tumors arising in the mediastinum
PMNSGCT) but also the most challenging from both onco-
ogic and surgical standpoints. Although histologically simi-
ar to their more commonly occurring testicular counter-
arts, PMNSGCT have an overall worse prognosis and
herefore have been categorized as “poor risk” along with
ther subsets of testicular nonseminomatous germ cell tu-
ors.
The majority of PMNSGCTs occur in males 20 to 40 years
f age. Most patients present symptomatic secondary to a
apidly growing anterior mediastinal mass. Computed tomo-
raphic (CT) scans typically demonstrate a large heteroge-
eous mass. Local invasion into lung, great vein, and pericar-
ium is common and even direct cardiac chamber/proximal
reat artery involvement can occasionally be present. Associ-
ted pericardial and pleural effusions are also common but
ypically not malignant in nature. For any young adult male
resenting with a mass in the anterior mediastinal compart-
ent, obtaining serum tumor markers (STMs), alpha-feto-
rotein, and human chorionic gonadotropin is an essential
omponent of clinical evaluation as significant elevation of
ither STM is diagnostic for PMNSGCT. Biopsy in these cases
s not only unnecessary but can be misleading due to sam-
ling error within these typically large and heterogeneous
eoplasms. We believe biopsy confirmation is only necessary
n rare PMNSGCT patients presenting with normal STMs or
atients with minor elevations of human chorionic gonado-
ropin, which can be present in pure seminomatous germ cell
ancer.
Histologically, these neoplasms comprise at least one non-
eminomatous germ cell cancer subtype (yolk sac cancer,
mbryonal carcinoma, or choriocarcinoma in order of fre-
uency), and frequently are mixed with some form of patho-
ogic teratoma ranging from mature teratoma to teratoma
ith immature elements (“stromal aytpia”), and finally, to
rank malignant degeneration of teratoma into the so-called
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hest and abdominal CT scans are standard imaging tests for
taging with other radiologic studies including positron
mission tomography scan and central nervous system mag-
etic resonance imaging obtained on an individual basis.
ated magnetic resonance imaging or echocardiogram can
e helpful to determine the presence of great vessel or cardiac
nvolvement; however, invasion may be subtle and only ap-
arent at the time of postchemotherapy surgical resection.
e therefore have cardiopulmonary bypass capabilities
vailable for these cases.
After diagnosis and staging, surgical resection for PMNSGCT
s initial therapy will rarely achieve local control and does not
reat metastatic disease, present in 20 to 25% of cases. Ap-
ropriate therapy typically begins with cisplatin-based che-
otherapy. Over the past 3 years we have utilized etoposide,
fosfamide, and cisplatin (VIP) for combination chemother-
py to eliminate the possibility of pulmonary toxicity with
leomycin before a major thoracic surgical procedure.1 Fol-
owing chemotherapy, there is typically resolution of pleural
nd pericardial effusions and a significant decrease in STMs.
here is also typically a reduction in tumor dimensions.
owever, a residual mediastinal mass (RM) is still invariably
resent and pathologically contains complete tumor necrosis
nly in a distinct minority of cases. Therefore, teratoma, per-
istent nonseminomatous germ cell cancer, or degenerative
ongerm cell cancer is pathologically present in most RMs for
hich surgery is indicated.
Optimally STMs normalize and surgery is planned after
dequate functional and hematologic recovery, which usu-
lly occurs between 4 and 6 weeks following completion of
hemotherapy. Although prechemotherapy STMs are highly
ensitive and specific to establish a diagnosis of PMNSGCT,
nfortunately, postchemotherapy STMs notoriously lack
redictive value for either residual malignant or benign
athologic conditions. Additionally, second-line chemother-
py has a very poor response rate for PMNSGCT refractory to
rst-line therapy.2 It has therefore been our policy over the
ast decade to recommend surgery for patients deemed op-
rable after first-line chemotherapy with persistently elevated
r even rising STMs. In this same regard, resection of the RM
ust proceed carefully with frozen section control of close
urgical margins even in patients with normal preoperative
postchemotherapy) STMs as up to a third of patients with
55
n
m
s
g
o
d
u
c
p
s
a
n
S
T
p
i
m
m
p
g
t
T
i
t
v
a
b
r
s
i
a
m
c
o
t
t
n
n
e
c
s
r
56 K.A. Keslerormal STMs will pathologically demonstrate malignant ele-
ents (germ cell or nongerm cell cancers).
Occasionally PMNSGCT patients will demonstrate the
o-called “growing teratoma syndrome” with paradoxical
rowth of a mediastinal mass associated with a rapid decrease
f STMs during chemotherapy. Chemotherapy should be
iscontinued and surgery undertaken if feasible in these sit-
ations. Of note, however, although teratoma is pathologi-
ally identified in many of these cases, over 50% of patients
resenting for surgery at our institution with this clinical
cenario have pathologically demonstrated areas of degener-
tive nongerm cell cancer or occasionally persistent nonsemi-
omatous germ cell cancer in the RM.
urgery
he basic premise of our surgical approach involves a com-
lete en-bloc removal of the RM, thymus, and surrounding
nvolved structures. Surgery for PMNSGCT is technically de-
anding as preoperative chemotherapy renders surrounding
ediastinal tissues fibrotic, obscuring normal anatomic
lanes. The effectiveness of cisplatin-based chemotherapy for
erm cell cancer, however, also usually results in extensive iumor necrosis, which is more marked around the periphery.
his finding usually allows a complete resection, which min-
mizes operative morbidity by preserving critical structures
hat abut but are not densely adherent to nor directly in-
olved with the RM, such lung, great veins, phrenic nerves,
nd occasionally, cardiac chambers where the “pericardial
arrier” has been violated. In general, we believe aggressively
emoving all visible residual disease but balancing dissection-
paring critical structures with liberal frozen section analysis
s warranted. This approach has allowed resection of virtually
ll RMs, including extremely large RMs, with tumor-free
argins.
Although all PMNSGCT arise in the anterior mediastinal
ompartment, the exact location, size, and degree of adjacent
rgan involvement of postchemotherapy masses are ex-
remely variable. The most critical initial decision therefore is
he determination of the surgical approach. A median ster-
otomy, bilateral anterior thoracotomy with transverse ster-
otomy (or the so-called “clamshell” incision), or anteriolat-
ral thoracotomy is chosen to optimize dissection around
ritical structures anticipated to be encountered at the time of
urgery. Based on cases referred to our institution, we cur-
ently utilize sternotomy and clam approaches with approx-
mate equal frequency and thoracotomy somewhat less often.
Mediastinal germ cell tumor resection 57Operative Technique
Figure 1 (A) CT of patient who underwent a sternotomy approach to remove a moderate-sized RM after chemotherapy. Note the
RMis substernalwithnoextension towardeitherpulmonaryhilum,whichmakes sternotomy theapproachof choice. (B)Standard
sternotomy approach to this residual mass. Only en-bloc removal of the thymus and pericardium was required in this case.
58 K.A. KeslerFigure 2 (A) CT of a patient who underwent a sternotomy approach to remove a moderate-sized RM after chemother-
apy. Note extension into the right pulmonary hilum in addition to the substernal component. (B) With the use of sternal
retractors used to mobilize internal thoracic arteries for coronary bypass procedures and instruments designed for
minimally invasive pulmonary surgery, en-bloc pulmonary resection can be accomplished through this approach. In
this case, extension into the pulmonary hilum precluded wedge resection. En-bloc right upper and middle lobectomies
and pericardectomy with resection of the right phrenic nerve resection were required. Although a clamshell approach
could have been utilized in this patient, the sternotomy approach facilitated recovery. The sternotomy approach also
provided better exposure to the anterior compartment as compared with a thoracotomy approach.
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Mediastinal germ cell tumor resection 59igure 3 (A) CT of a patient who underwent a clamshell
pproach to remove a large RM after chemotherapy.
ote a large substernal component and significant ex-
ension into the left pleural space with effacement of
ulmonary hilum. (B) Patient positioning is supine
ith both arms crossed, padded, and then secured to
n ether screen above the head. In this case, the inci-
ion extended from the right mid clavicular line to the
eftward mid axillary line. En-bloc left bracheocephalic
ein, left upper lobectomy, and pericardectomy was
equired based on intraoperative findings.
60 K.A. Kesler
4one-third of patients, wedge resection in 20%, and total pneumonectomy in 5% of cases.
Mediastinal germ cell tumor resection 61™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
Figure 4 CT of two patients who underwent a right (A) and left (B) thoracotomy approach to remove moderate-sized RMs
after chemotherapy. Note no substernal component to the RM in either patient. (C) The patient is positioned in the normal
lateral decubitus position and then slightly rotated outward. Padding and then securing the ipsilateral arm to an ether screen
can improve exposure to the anterior chest. Critical structures anticipated during dissection in these types of cases are the
pulmonary hilum and phrenic nerves bilaterally. The superior vena cava will additionally be encountered during dissection
of the rightward mass and the vagus nerve with its recurrent branch will be encountered on the left. The pericardium is
usually a successful barrier to tumor involvement of the ascending aorta by the right-sided RMs and main pulmonary artery
by the left-sided RMs; however, provisions to surgically remove portions of these great arteries including the availability ofFigure 5 Although many RMs abut the parietal pleura, we have encountered chest wall/sternal involvement, requiring en-bloc
resection in only 3 of 176 total PMNSGCT patients surgically treated at our institution to date. For most cases where the CT scan
shows the RM to abut the chest wall, however, there is no evidence of frank chest wall/sternal involvement, and we begin with an
extrapleural dissection until it can be determined that the RM does or does not involve the parietal pleura. The pleural space is
entered at any point if the RM is found not to be adherent. If the RM is adherent, then at least a 1-cm rim of visibly normal parietal
pleura is removed en bloc with a frozen section of the pleural margin. From this point, given the variability in the location, size, and
degree of adjacent organ involvement of postchemotherapy masses, unfortunately there is no consistent step-by-step surgical
routine. Ingeneral,however, a surgical strategyproceeding from“themost easy to themostdifficult”worksbest.Wetypicallybegin
bydissectingadherent lungtissuefromtheRM,particularly if this involves lysisoffilamentousadhesionsorstapledwedgeresection,
removing a rim of lung parenchyma more densely adherent to the RM. Stapled wedge resection is facilitated by passage of a red
rubber catheter between the RM and pulmonary hilum for elevation and lateral retraction of the lung parenchyma before stapler
division. Invasion of the RM into a significant amount of pulmonary parenchyma or pulmonary hilum usually requires formal
anatomic resection, which can be done at this point or after further dissection. In our institution’s experience, over half of the
PMNSGCT patients require some form of en-bloc pulmonary resection. Formal lobectomy has been required in approximatelycardiopulmonary bypass for cases of RM involvement should be made.
62 K.A. KeslerFigure 6 We typically proceed with dissection of uninvolved tissues superior and inferior to the RM. The thymic horns are
rarely involved and can be easily mobilized from the neck. Below, the pericardial fat is mobilized along with uninvolved
contiguous thymic tissue to within 1 cm of the RM. Typically the RM is densely adherent to the pericardium. As there is little
downside to pericardectomy, no attempt is made to separate the RM from the pericardium and the pericardium is removed
en bloc with a 1-cm tumor-free margin. Inspection of underlying cardiac structures including determination if the RM has
transgressed the pericardial barrier is made at this time. Occasionally inflammatory adhesions to the epicardial surface are
present and can be lysed with frozen section control. Division of the pericardium around the inferior aspect of the RM may
also facilitate dissection around more critical structures such as great veins and phrenic nerves. Many pericardial defects are
of no consequence. Pericardial reconstruction should be performed, however, by using either fenestrated permanent thin-
walled prosthesis or absorbable mesh prosthesis, where any possibility of cardiac herniation exists. v. vein.
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Mediastinal germ cell tumor resection 63igure 7 Many RMs are in proximity to the left
racheocephalic vein. Although an attempt is
ade to spare the left bracheocephalic vein with
rozen section control where there is no radio-
raphic or visible evidence of frank invasion, if the
M is found to be densely adherent to the left
racheocephalic vein, then en-bloc removal with-
ut reconstruction is warranted as there is typically
nly minor and temporary left upper extremity
enous insufficiency in these cases. If both
racheocephalic veins and the superior vena cava
SVC) are removed en bloc with the RM, which in
ur experience has been necessary in approxi-
ately 10% of cases, we prefer unilateral right
racheocephalic to SVC reconstruction utilizing
n externally stented polytetrafluoroethylene vas-
ular prosthesis. Care must be taken to avoid
njury to the right phrenic nerve if it has been pre-
erved during clamping of the right bracheoce-
halic vein and SVC. The proximal anastomosis is
one first, followed by the distal anastomosis after
he prosthesis is cut to length by using 5-0 poly-
etrafluoroethylene suture. Although somewhat
ore difficult than left bracheocephalic recon-
truction, we believe that the “straight, short, and
ownward” course of a right bracheocephalic to
VC vascular prosthesis along with a higher ve-
ous flow if the left bracheocephalic vein is not
econstructed will promote patency. We have re-
onstructed partial SVC defects with a patch of
utologous pericardium. n.nerve; SVC supe-
ior vena cava; v. vein.
C
C
m
e
e
p
r
d
a
c
n
M
W
i
a
r
r
t
t
a
m
s
m
v
C
P
c
64 K.A. Keslerardiopulmonary Bypass
ardiopulmonary bypass has been required in approxi-
ately 5% of our cases. Most of these patients required
xcision and patch repair of the right atrial free wall; how-
ver, we have had two patients who underwent patch re-
air of the main pulmonary artery. These excisions and
epairs can usually be performed with normothermic car-
iopulmonary bypass using bicaval venous cannulation,
llowing the heart to beat “empty” with control of the
oronary sinus return through a cardiotomy sucker when
ecessary.
etastatectomy
hen required, the timing of pulmonary metastastectomy is
Figure 8 One phrenic nerve is almost always found in clo
unilateral phrenic nerve invasion with preoperative CT
nerve resection will then facilitate the remaining dissectio
ability to spare or the necessity to remove a phrenic ner
time of surgery however. In these cases, phrenic nerve
procedure. The pericardiophrenic fat can be densely ad
fibrotic soft tissue surrounding the RM. In these cases
control can be challenging but minimizes short- and l
utilized, we prefer using a standard sternal retractor duri
artery retractors with medial retraction on the tumor m
nerve is initially identified superiorly and inferiorly to t
of a clamp or cold blade of an electrocautery unit can fa
when there is dense peritumoral fibrosis without neura
surgical clips when encountered. En-bloc phrenic nerve
cases. Bilateral phrenic nerve removal has never been n
Diaphragmatic plication is performed after removal of th
required with phrenic nerve resection. n.  nerve.ndividualized based on several factors including the surgical fpproach to the RM, the magnitude of pulmonary resection
equired to remove the RM, and the magnitude of pulmonary
esection required for metastastectomy. Pulmonary metastatec-
omy is usually accomplished at the time of surgery to remove
he RM; however, we do not hesitate to stage pulmonary met-
statectomy after recovery if deemed prudent. Finally, approxi-
ately 10% of patients in our surgical series have undergone
taged extrathoracic metastatectomy for either synchronous or
etachronous metastases to other organs including bone, cer-
ical lymph node, and central nervous system.
onclusions
MNSGCT represent a challenging group of malignant germ
ell tumors and survival outcome is dependant on both success-
ximity to the RM. When there is clear evidence of frank
nce of diaphragmatic paralysis, early en-bloc phrenic
ding exposure to hilar structures. More commonly, the
ose proximity to the RM can only be determined at the
ion is best deferred until the later stages of the surgical
to the RM and at times inperceivably “blends” into the
empt at freeing the phrenic nerve with frozen section
m morbidity. When a sternotomy approach has been
phrenic nerve dissection as opposed to internal thoracic
expose the pericardiophrenic structures. The phrenic
abutting the RM. Careful blunt dissection with the tip
developing a plane between the phrenic nerve and RM
ion, controlling pericardiophrenic branch vessels with
on has been required in almost one-third of our surgical
y in our experience and should be avoided at all costs.
nly if an ipsilateral lobectomy or pneumonectomy is notse pro
evide
n inclu
ve in cl
dissect
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Mediastinal germ cell tumor resection 65easible. New chemotherapy strategies, which reduce the inci-
ence of persistent nonseminomatous germ cell and/or non-
erm cell cancer, need continued investigation. Although over-
ll survival is inferior to nonseminomatous germ cell tumors of
esticular origin, favorable subsets with pathologic evidence of
ither complete tumor necrosis or teratoma in the resected re-
idual disease have been identified.3 An aggressive surgical ap-
roach after cisplatin-based chemotherapy can result in long-
erm survival even in patients with persistent nonseminomatous
erm cell and/or nongerm cell cancer and is warranted in these
therwise young and healthy patients.eferences
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